Cite

HARVARD Citation

    Adeberg, S. et al. (n.d.). PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma. Radiotherapy and oncology. pp. 90-. [Online]. 
  
Back to record